The Latest

Long-Acting Antiretrovirals photo illo

ATLAS, FLAIR, and the Upcoming Arrival of Long-Acting Injectable HIV Treatment

The likely launch of injectable cabotegravir/rilpivirine in early 2020 will be interesting, writes David Wohl, M.D. One big question: How smoothly will the rollout go?

By David Alain Wohl, M.D.
Islatravir photo illo

Islatravir Is Potent and Long-Lasting -- and May Be Having an Identity Crisis

This is clearly an antiretroviral not built for daily administration. But then what is it destined for?

By David Alain Wohl, M.D.